BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 5820999)

  • 1. Treatment of parkinsonism with levodopa.
    Yahr MD; Duvoisin RC; Schear MJ; Barrett RE; Hoehn MM
    Arch Neurol; 1969 Oct; 21(4):343-54. PubMed ID: 5820999
    [No Abstract]   [Full Text] [Related]  

  • 2. L-dopa in the treatment of parkinsonism.
    Haleem MA
    Gerontol Clin (Basel); 1972; 14(4):242-8. PubMed ID: 4634915
    [No Abstract]   [Full Text] [Related]  

  • 3. L-Dopa treatment in Parkinson's Disease.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1970; 4(6):348-69. PubMed ID: 4932969
    [No Abstract]   [Full Text] [Related]  

  • 4. A year's experience of L-DOPA in the treatment of Parkinson's disease.
    Guidetti B; Giuffrè R
    Acta Neurochir (Wien); 1971; 24(2):81-8. PubMed ID: 5112463
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined treatment of parkinsonism with L-dopa and amantadine.
    Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
    Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of parkinsonism with levodopa.
    Sutcliffe RL
    Gerontol Clin (Basel); 1974; 16(1):151-6. PubMed ID: 4855131
    [No Abstract]   [Full Text] [Related]  

  • 7. [Levodopa and Parkinsonism. A double-blind study].
    Pakkenberg H; Dupont E; Garde B; Hansen E; Melsen S; Vestberg F
    Ugeskr Laeger; 1971 Nov; 133(46):2275-9. PubMed ID: 4944650
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of and possible differences in tolerance to L-dopa tablets with different rates of release of the active substance.
    Völler GW; Muschard F
    Acta Neurol Scand; 1974; 50(3):391-3. PubMed ID: 4525037
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indications and results of monoamine treatment in parkinsonian syndromes].
    Boudin G; Pépin B; Guillard A; Fabiani JM; Haguenau M
    Rev Neurol (Paris); 1972 Jul; 127(1):79-97. PubMed ID: 4520464
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term treatment of Parkinsonism with L-dopa].
    Presthus J; Holmsen R
    Tidsskr Nor Laegeforen; 1972 Nov; 92(33):2262-6. PubMed ID: 4630916
    [No Abstract]   [Full Text] [Related]  

  • 11. L-dopa in idiopathic parkinsonism.
    Calne DB; Stern GM; Spiers AS; Laurence DR
    Lancet; 1969 Nov; 2(7628):973-6. PubMed ID: 4186975
    [No Abstract]   [Full Text] [Related]  

  • 12. L-dopa. II.
    Br Med J; 1970 Nov; 4(5734):541-2. PubMed ID: 4099003
    [No Abstract]   [Full Text] [Related]  

  • 13. Levodopa in postencephalitic parkinsonism.
    Hunter KR; Stern GM; Sharkey J
    Lancet; 1970 Dec; 2(7687):1366-7. PubMed ID: 4098944
    [No Abstract]   [Full Text] [Related]  

  • 14. L-Dopa in the treatment of parkinsonism.
    Calne DB
    Clin Pharmacol Ther; 1970; 11(6):789-801. PubMed ID: 4921292
    [No Abstract]   [Full Text] [Related]  

  • 15. Levodopa in treating Parkinsonism.
    O'Doherty DS
    Am Fam Physician; 1971 Nov; 4(5):95-9. PubMed ID: 5117507
    [No Abstract]   [Full Text] [Related]  

  • 16. Levodopa in Parkinsonism.
    Weiss JL; Chase TN
    Drugs; 1971; 2(4):257-61. PubMed ID: 4948349
    [No Abstract]   [Full Text] [Related]  

  • 17. Sustained levodopa therapy in parkinsonism.
    Hunter KR; Shaw KM; Laurence DR; Stern GM
    Lancet; 1973 Oct; 2(7835):929-31. PubMed ID: 4126558
    [No Abstract]   [Full Text] [Related]  

  • 18. A second report on Levodopa.
    Med Lett Drugs Ther; 1969 Sep; 11(18):73-5. PubMed ID: 5394281
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of the Parkinson syndrome with amantadine].
    Hartmann-von Monakow K
    Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
    Rosati G; Agnetti V; Mura F; Granieri E
    Minerva Med; 1974 May; 65(33):1811-23. PubMed ID: 4602058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.